Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1206 of 5804
-
New pill aims to quiet heartburn without damaging the esophagus
Symptom relief Not yet recruitingThis study aims to evaluate the efficacy and safety of JP-1366 in Patients with NERD
Phase: PHASE3 • Sponsor: Onconic Therapeutics Inc. • Aim: Symptom relief
Last updated Jun 26, 2026 14:58 UTC
-
Could a simple head tilt save stroke Patients' brains?
Disease control Recruiting nowRecent studies suggest that head-down positioning (HDP) intervention may improve outcomes in ischemic stroke. In the era of reperfusion therapy, a key protective strategy is to administer neuroprotective interventions before recanalization to reduce the loss of the ischemic penum…
Phase: NA • Sponsor: General Hospital of Shenyang Military Region • Aim: Disease control
Last updated Jun 26, 2026 17:27 UTC
-
Breath training could ease lingering concussion symptoms in veterans
Symptom relief Recruiting nowMany combat veterans (c-Vs), service members (SMs) and civilians with mild traumatic brain injury (mTBI, also termed concussion) suffer from persistent post-concussion symptoms (PPCS) that degrade physical and cognitive well-being and have been linked with early neurodegeneration…
Phase: PHASE2, PHASE3 • Sponsor: Virginia Commonwealth University • Aim: Symptom relief
Last updated Jun 26, 2026 18:10 UTC
-
New AI-Powered insulin system could free people with diabetes from constant meal calculations
Disease control Recruiting nowA randomized cross-over trial assessing glycemic control on Automated insulin delivery as Adaptive Network (AIDANET) algorithm when used in three modes: AIDANET-Fully Closed Loop (FCL), AIDANET-Hybrid Closed Loop (HCL) and AIDANET allowing a mix between FCL and HCL. There will be…
Phase: NA • Sponsor: Sue Brown • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New eye drops aim to banish night glare after laser surgery
Symptom relief OngoingThe goal of this clinical trial is to learn if Phentolamine Ophthalmic Solution works to treat adults that have had keratorefractive surgery and have decreased visual acuity under mesopic conditions. It will also learn about the safety of Phentolamine Ophthalmic Solution. The mai…
Phase: PHASE3 • Sponsor: Ocuphire Pharma, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:01 UTC
-
New pill could tame overactive thyroid in Graves' disease
Disease control Recruiting nowThis is a parallel group, Phase 2, 2-arm study to measure the treatment effect and safety of rilzabrutinib dose 1 or rilzabrutinib dose 2 in participants with Graves' disease, with and without Graves' orbitopathy, aged 18 years or older. Study details include: * Screening perio…
Phase: PHASE2 • Sponsor: Sanofi • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New injection shows promise for tough lymphoma cases
Disease control Recruiting nowThis is a single center, single arm, open-label, dose escalation, phase 1 study to evaluate the safety, tolerability and preliminary efficacy of KSV01 Injection for patients with diffuse large B-cell lymphoma.
Phase: PHASE1 • Sponsor: TCRx Therapeutics Co.Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
Cheaper version of ustekinumab tested for painful Behçet's ulcers
Disease control Recruiting nowThis non-interventional study is an observational cohort with parallel groups aiming primarily to describe the success of biosimilar of ustekinumab in Behçet's syndrome in whom conventional approaches have failed or are not suitable well tolerated, and then to compare with patien…
Sponsor: Groupe français d'étude des Maladies Inflammatoires de loeil • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
New drug shows promise for rectal cancer patients
Disease control Recruiting nowThis is an observational, retrospective-prospective, multicentre trial enrolling all patients included in the AIFA monitoring registry of Dostarlimab for the indication in rectal cancer. The aims of the study are to describe the clinical outcomes and safety of patients with dMMR/…
Sponsor: National Cancer Institute, Naples • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
AI could predict which heart patients need extra care after stent surgery
Knowledge-focused Recruiting nowCoronary artery disease remains a leading cause of global mortality. Although percutaneous coronary intervention (PCI) improves patient outcomes, the long-term risk of major adverse cardiovascular events (MACE) driven by the progression of non-target lesions (NTLs) remains substa…
Sponsor: China-Japan Friendship Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:07 UTC
-
Urine test may spare bladder cancer patients from unnecessary second surgery
Diagnosis Recruiting nowHigh-risk non-muscle-invasive bladder cancer (NMIBC) carries a substantial risk of residual disease after initial transurethral resection of bladder tumor (TURBT). Current guidelines recommend a second TURBT (re-TURBT) within 2-6 weeks for patients with stage T1 disease to remove…
Sponsor: Tianjin Medical University Second Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:09 UTC
-
Blood test may replace biopsies for bile duct cancer patients
Knowledge-focused Recruiting nowBiliary tract cancer (BTC) is a rare and heterogeneous disease with high incidence and mortality in Korea. Molecular profiling has enabled the identification of actionable alterations such as Isocitrate Dehydrogenase 1 (IDH1) mutations, FGFR2 fusions, ERBB2 amplifications, and dM…
Sponsor: CHA University • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Herbal extract shows promise for stiff skin and joints in transplant survivors
Disease control Recruiting nowSclerotic chronic graft-versus-host disease (scl-cGVHD) is a severe subtype of chronic GVHD after allogeneic hematopoietic stem cell transplantation (allo-HSCT), characterized by skin sclerosis, fascial involvement, and restricted joint mobility, leading to substantial functional…
Phase: PHASE2 • Sponsor: WeiShi • Aim: Disease control
Last updated Jun 27, 2026 12:38 UTC
-
Could a stroke pill boost brainpower in elderly epilepsy patients?
Symptom relief Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled trial evaluating the safety and efficacy of butylphthalide soft capsules for treating cognitive impairment in elderly patients with focal epilepsy. Study Population: 220 elderly patients (60-85 years) with focal…
Phase: PHASE4 • Sponsor: First Affiliated Hospital of Wenzhou Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can VR games sharpen the minds of people with mental illness?
Symptom relief OngoingThis randomized controlled trial aims to evaluate the effectiveness of a virtual reality-based cognitive remediation (VRCR) intervention in improving cognitive performance and psychosocial functioning in individuals with schizophrenia spectrum disorders (SSD) and bipolar disorder…
Phase: NA • Sponsor: Università degli Studi di Brescia • Aim: Symptom relief
Last updated Jun 27, 2026 13:05 UTC
-
New hope for lung cancer patients whose drugs have failed
Disease control Recruiting nowNon-small cell lung cancer (NSCLC) accounts for over 85% of lung cancers. Approximately 30-40% of East Asian adenocarcinoma patients harbor EGFR mutations. Third-generation EGFR-TKIs achieve a median PFS of about 20 months as first-line therapy, but resistance eventually develops…
Phase: PHASE2 • Sponsor: Betta Pharmaceuticals Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New pill aims to ease burning nerve pain in diabetes
Symptom relief Not yet recruitingThis is a multi-center, randomized, double-blind, placebo-controlled study design evaluating the safety, efficacy, and PK parameter of HL-1186 tablet for diabetic peripheral neuropathic pain.
Phase: PHASE2 • Sponsor: Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. • Aim: Symptom relief
Last updated Jun 26, 2026 14:42 UTC
-
Robot vs surgeon: which knee replacement works better?
Disease control Not yet recruitingBackground: Total knee arthroplasty is a golden standard procedure for end-stage knee osteoarthritis. However, up to 20% of the patients are not satisfied with the outcome. Recently, robotic-assisted TKAs have been developed to offer individual alignment and to achieve accuracy i…
Phase: NA • Sponsor: Satakunta Central Hospital • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Phone app alerts could slash stroke recurrence risk
Disease control Not yet recruitingThis study applied an application to provide early warnings and advice for stroke patients and explored the impact of this intervention on reducing the risk of stroke recurrence
Phase: NA • Sponsor: Xuanwu Hospital, Beijing • Aim: Disease control
Last updated Jun 26, 2026 14:08 UTC
-
New rinse aims to stop deadly heart device infections
Prevention Not yet recruitingInfections associated with cardiovascular implantable electronic devices (CIEDs) represent one of the major postoperative complications in interventional cardiology. These infections-including lead-related endocarditis, subcutaneous pocket infections, and sepsis-are characterized…
Sponsor: University of Calabria • Aim: Prevention
Last updated Jun 26, 2026 13:37 UTC